We are leaving our position in a medical care action to raise some cash.
Shortly after the opening bell, we will leave our position in Ge Healthcare, selling 550 shares at approximately $ 65.…
investment strategy
Trump tariffs will challenge the big pharmaceuticals. Here are well positioned actions
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
Do not ignore the impact of pharmaceutical rates, says an analyst. Where we stop in Bristol Myers
The drug stock is higher during the past month, while the S&P 500 has retired sharply.
We are buying more shares of 2 shares as the broader market sinks more
We are doing our first exchanges of the week. We are buying 25 shares from Danaher to approximately $ 207…
Life sciences are under pressure due to possible NIH funds cuts
A recent Trump administration movement to substantially reduce the funds of the National Health Institutes for research institutions throughout the…
2 portfolio actions that should benefit from an impulse in the spending of major Americans
Home Depot and Ge Healthcare are the companies that Mizuho believes that he will receive an impulse from an American…
We are reserving profits in a rally rotation game and buying another 2 on the dip
We are making a handful of more offices on Tuesday. Sell 75 shares of Ge Healthcare to approximately $ 86…
Senator Blumenthal asks Visa Details about Elon Musk X Payments Deal
Senator Richard Blumenthal, D-CT, speaks during a hearing of the Senate Judicial Committee on the insurrection of January 6, in…
What Cramer wants to hear from Nvidia, Salesforce, in addition, Lilly does what no other can
Every day of the week, the CNBC Investing Club with Jim Cramer has a live broadcast of the “morning meeting”…
Ge Healthcare triggers 9% in Beat profits, wise guide. Here is our new target price
Things continue to seek the actions of Ge Healthcare this year. The actions of the Medical Technology Company increased approximately…